Another study reported that lncRNA and MDM2 influence cancer progression through ubiquitination in bladder cancer, particularly investigating the mechanism by which lncRNA plasmacytoma variant translocation 1 (PVT1) regulates adriamycin (ADM) resistance in bladder cancer cells. This evidence concerns the gene MDM2 and urinary bladder carcinoma.